PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes

Journal of the American Society of Nephrology : JASN
Rania NasrallahRichard L Hébert

Abstract

An important measure of cardiovascular health is obtained by evaluating the global cardiovascular risk, which comprises a number of factors, including hypertension and type 2 diabetes, the leading causes of illness and death in the world, as well as the metabolic syndrome. Altered immunity, inflammation, and oxidative stress underlie many of the changes associated with cardiovascular disease, diabetes, and the metabolic syndrome, and recent efforts have begun to elucidate the contribution of PGE2 in these events. This review summarizes the role of PGE2 in kidney disease outcomes that accelerate cardiovascular disease, highlights the role of cyclooxygenase-2/microsomal PGE synthase 1/PGE2 signaling in hypertension and diabetes, and outlines the contribution of PGE2 to other aspects of the metabolic syndrome, particularly abdominal adiposity, dyslipidemia, and atherogenesis. A clearer understanding of the role of PGE2 could lead to new avenues to improve therapeutic options and disease management strategies.

References

Jul 1, 1984·The Journal of Clinical Endocrinology and Metabolism·B RichelsenO Pedersen
Sep 1, 1984·Current Eye Research·N Naveh-FlomanM Belkin
May 4, 1995·The New England Journal of Medicine·C M Clark, D A Lee
Feb 1, 1993·Neuroscience·S C Ahlgren, J D Levine
Jan 8, 1998·British Journal of Pharmacology·N A Calcutt, S R Chaplan
Sep 10, 1999·Prostaglandins & Other Lipid Mediators·J D BørglumB Richelsen
May 5, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A FennekohlG P Püschel
Jul 18, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·N EnomotoR G Thurman
Sep 21, 2000·American Journal of Physiology. Renal Physiology·K E Purdy, W J Arendshorst
Apr 17, 2001·Hypertension·J R SowersE D Frohlich
Feb 1, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Antonia M JoussenAnthony P Adamis
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Hisashi MakinoKazuwa Nakao
Apr 29, 2004·American Journal of Physiology. Renal Physiology·Frank SchwedaArmin Kurtz
Sep 1, 2004·Biochemical and Biophysical Research Communications·Hiroaki TsuboiAtsushi Ichikawa
Sep 15, 2004·European Journal of Pharmacology·Surya P AyalasomayajulaUday B Kompella
Sep 17, 2004·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Yunpeng DuT S Kern
Nov 20, 2004·Science·Karine M EganGarret A Fitzgerald
Dec 9, 2004·American Journal of Physiology. Renal Physiology·Reena RaoChuan-Ming Hao
Dec 8, 2005·American Journal of Physiology. Renal Physiology·Lisa M Harrison-BernardBenjamin J Bivona
Sep 7, 2006·American Journal of Physiology. Renal Physiology·Rania NasrallahRichard L Hébert
Sep 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Miao WangGarret A FitzGerald
Nov 18, 2006·Canadian Journal of Physiology and Pharmacology·Sherine RahalChris R J Kennedy
Jan 5, 2007·Clinical and Experimental Pharmacology & Physiology·Radko KomersSharon Anderson
Jan 24, 2007·The Journal of Experimental Medicine·Sabrina GrossJean-Etienne Fabre
Feb 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Manuel Sanchez-AlavezTamas Bartfai
Jul 24, 2007·Prostaglandins & Other Lipid Mediators·Ajay NarasimhaSrinivasa T Reddy
Aug 31, 2007·American Journal of Physiology. Renal Physiology·Gerard ElbergMartin A Turman
Sep 1, 2007·Clinical Science·Rania NasrallahRichard L Hébert

❮ Previous
Next ❯

Citations

Apr 20, 2017·International Journal of Molecular Sciences·Yusuke KandaFutoshi Okada
Jun 20, 2017·Expert Opinion on Therapeutic Patents·Anastasia PsarraGeorge Kokotos
Aug 4, 2018·Analytical and Bioanalytical Chemistry·Zhi-Xin YuanChristopher E Ramsden
Oct 18, 2018·American Journal of Physiology. Renal Physiology·Ida AringerKathrin Eller
Feb 16, 2019·Journal of the American Heart Association·Marcela HerreraThomas M Coffman
Dec 19, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Rania NasrallahRichard L Hébert
Mar 20, 2020·Critical Reviews in Food Science and Nutrition·Maushmi S Kumar, Simran A Sharma
Oct 16, 2019·Inflammopharmacology·Benjamin G SpencerJohn W Finnie
Sep 11, 2019·International Journal of Molecular Sciences·Jia-Feng ChangWei-Ning Lin
Sep 19, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Rania NasrallahRichard L Hébert
Jun 17, 2020·Journal of Food Biochemistry·Nor Shahira Solehah UmranNur Iliyani Mohd Ishak
Jul 25, 2019·International Journal of Molecular Sciences·Ryuji OkamotoMasaaki Ito
Dec 14, 2018·Journal of the American Society of Nephrology : JASN·Atsuko Y HigashiGregory R Dressler
Mar 10, 2020·The Journal of Toxicological Sciences·Sosuke KishiYoko Matsuda
Aug 16, 2019·Biochimica Et Biophysica Acta. Molecular Cell Research·Marie-Christin SchulzGerald Schwerdt
Jul 27, 2021·Frontiers in Physiology·Gustavo Jose Justo da SilvaAlessandro Cataliotti
Jul 14, 2021·British Journal of Pharmacology·Md Abdul Hye KhanJohn D Imig
Apr 19, 2019·ACS Medicinal Chemistry Letters·Letizia GiampietroAntonio Lavecchia
Aug 28, 2021·Journal of Personalized Medicine·Luz María GonzálezGuillermo Gervasini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here